GB1385620A - Carbazoles - Google Patents

Carbazoles

Info

Publication number
GB1385620A
GB1385620A GB3496873A GB3496873A GB1385620A GB 1385620 A GB1385620 A GB 1385620A GB 3496873 A GB3496873 A GB 3496873A GB 3496873 A GB3496873 A GB 3496873A GB 1385620 A GB1385620 A GB 1385620A
Authority
GB
United Kingdom
Prior art keywords
amino
group
lower alkyl
formula
lower alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3496873A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1385620A publication Critical patent/GB1385620A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1385620 Carbazoles F HOFFMANN-LA ROCHE & CO AG 23 July 1973 [24 July 1972] 34968/73 Heading C2C The invention comprises compounds of the formula wherein R represents a hydrogen or halogen atom or a hydroxy, cyano, lower alkyl, hydroxy-(lower alkyl), lower alkoxy, acyl, benzyloxy, lower alkylthio, trifluoromethyl, carboxy, carbo-(lower alkoxy), nitro, amino, mono- (lower alkyl)amino, di(lower alkyl)amino, sulphamoyl, di(lower alkyl)sulphamoyl or difluoromethylsulphonyl group and R 1 represents a halogen atom or a hydroxy, cyano, lower alkyl, hydroxy-(lower alkyl), lower alkoxy, acyl, acylamido, benzyloxy, lower alkylthio, trifluoromethyl, carboxy, carbo-(lower alkoxy), nitro, amino, mono(lower alkyl)amino, di- (lower alkyl)amino, sulphamoyl, di(lower alkyl) - sulphamoyl or difluoromethylsulphonyl group or R and R 1 together represent a lower alkylenedioxy group, R 2 represents the grouping in which A represents a cyano, hydroxy, lower alkoxy, amino(lower alkoxy), mono(lower alkyl)- amino-(lower alkoxy), di(lower alkyl)amino- (lower alkoxy) group or the grouping wherein B represents a hydroxy, carboxy, lower alkoxy, amino, hydroxyamino, mono(lower alkyl)amino, di(lower alkyl)amino, amino-(lower alkoxy), mono(lower alkyl)amino-(lower alkoxy), di(lower alkyl)amino - (lower alkoxy) group, Y and X each represent a hydrogen atom or a lower alkyl group and n stands for 1 to 7, and R 3 represents a hydrogen atom or a lower alkyl, acyl, halo-substituted acyl, carboxy- (lower alkyl), (lower alkoxycarbonyl)-(lower alkyl), aralkyl or haloaralkyl group, or R 1 represents a hydrogen atom when R, X and R 3 each represent a hydrogen atom, Y represents a lower alkyl group and B represents a hydroxy or lower alkoxy group, and, when R or R 1 represents a carboxy and/or when B represents a hydroxy or carboxy group, salts thereof with bases and, when R or R 1 represents an amino or mono (lower alkyl)amino or di(lower alkyl)amino group and/or when B or A represents an amino- (lower alkoxy) or mono(lower alkyl)amino- (lower alkoxy) or di(lower alkyl)amino-(lower alkoxy) group, addition salts thereof with acids. The term lower alkyl means an alkyl group of 1-7 carbon atoms, acyl means alkanoyl derived from a carboxylic acid containing 1-7 carbon atoms and aryl means phenyl optionally substituted by halogen, trifluoromethyl, lower alkyl, lower alkoxy, nitro, amino, lower alkylamino and di(lower alkyl)amino. The compounds may be prepared by reacting a compound of the formula with an aromatizing agent, for the manufacture of an ester of Formula I in which R or R 1 represents a carbo-(lower alkoxy) group or B represents a lower alkoxy group esterifying an acid of Formula I in which R or R 1 represents a carboxy group or B represents a hydroxy group, for the manufacture of an acid of Formula I in which R or R 1 represents a carboxy group, R 3 represents a carboxy-(lower alkyl) group or B represents a hydroxy group hydrolysing an ester of Formula I in which R or R 1 represents a carbo-(lower alkoxy) group, R 3 represents a (lower alkoxycarbonyl)-(lower alkyl) group or B represents a lower alkoxy group, for the manufacture of a compound of Formula I in which R 1 represents an amino group reacting a compound of Formula I in which R 1 represents an acylamido group with an inorganic acid, if desired replacing a hydrogen atom denoted by R 3 in a compound of Formula I by an acyl or (lower alkoxycarbonyl)-(lower alkyl) group, for the manufacture of a compound of Formula I in which R or R 1 represents a di(lower alkyl)amino group alkylating a compound of Formula I in which R or R 1 represents an amino group, for the manufacture of a compound of Formula I in which R, R 1 or A represents a hydroxy group hydrolysing an ether of Formula I in which R, R 1 or A represents a lower alkoxy group, if desired converting a compound of Formula I in which A represents a hydroxy group into a compound of Formula I in which A represents a lower alkoxy, amino-(lower alkoxy), mono(lower alkyl)amino- (lower alkoxy) or di(lower alkyl)amino-(lower alkoxy) group, for the manufacture of an alcohol of Formula I in which A represents a hydroxy group reducing an ester of Formula I in which B represents a lower alkoxy group, if desired converting a hydroxy group denoted by B in an acid of Formula I or in a salt of such an acid with a base into an amino-(lower alkoxy), mono(lower alkyl)amino-(lower alkoxy) or di- (lower alkyl)amino-(lower alkoxy) group, for the manufacture of an optically active isomer of a compound of Formula I resolving a racemate of Formula I into its optically active isomers and isolating the desired isomer and for the manufacture of a salt of a compound of Formula I in which R or R 1 represents a carboxy group and/or B represents a hydroxy or carboxy group or in which R or R 1 represents an amino, mono(lower alkyl)amino or di(lower alkyl)amino group and/or B or A represents an amino-(lower alkoxy), mono(lower alkyl)amino- (lower alkoxy) or di(lower alkyl)amino-(lower alkoxy) group reacting such a compound of Formula I with a base or an acid. The compounds may be used as anti-inflammatory, analgesic and anti-rheumatic agents.
GB3496873A 1972-07-24 1973-07-23 Carbazoles Expired GB1385620A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27414272A 1972-07-24 1972-07-24

Publications (1)

Publication Number Publication Date
GB1385620A true GB1385620A (en) 1975-02-26

Family

ID=23046965

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3496873A Expired GB1385620A (en) 1972-07-24 1973-07-23 Carbazoles

Country Status (26)

Country Link
JP (1) JPS5740144B2 (en)
KR (1) KR780000289B1 (en)
AR (1) AR205331A1 (en)
AT (1) AT325607B (en)
AU (1) AU475534B2 (en)
BE (1) BE802596A (en)
CA (1) CA1026348A (en)
CH (1) CH587819A5 (en)
DD (1) DD107681A5 (en)
DE (1) DE2337340C2 (en)
DK (1) DK138537B (en)
FI (1) FI59244C (en)
FR (1) FR2193611B1 (en)
GB (1) GB1385620A (en)
HK (1) HK49878A (en)
HU (1) HU167611B (en)
IE (1) IE37942B1 (en)
IL (1) IL42799A (en)
KE (1) KE2847A (en)
LU (1) LU68071A1 (en)
MY (1) MY7800315A (en)
NL (1) NL169877C (en)
NO (1) NO142865C (en)
SE (2) SE402283B (en)
SU (1) SU509220A3 (en)
ZA (1) ZA734047B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0060445A1 (en) * 1981-03-12 1982-09-22 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Process for the resolution of racemates and lactone esters used in said process
EP0239306A2 (en) 1986-03-27 1987-09-30 Merck Frosst Canada Inc. Tetrahydrocarbazole esters
EP0304156A1 (en) * 1987-07-21 1989-02-22 Merck Frosst Canada Inc. Cyclohept b indolealkanoic acids
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146542A (en) * 1978-06-12 1979-03-27 Hoffmann-La Roche Inc. Dihydrocarbazole acetic acid and esters thereof
US4150031A (en) * 1978-06-26 1979-04-17 Hoffmann-La Roche Inc. Hydroxy methyl carbazole acetic acid and esters
US4158007A (en) * 1978-08-21 1979-06-12 Hoffmann-La Roche Inc. Carbazole methyl malonates
JPS6040256U (en) * 1983-08-25 1985-03-20 伊東 璋 Container cleaning machine
ATE61047T1 (en) * 1986-01-23 1991-03-15 Merck Frosst Canada Inc TETRAHYDROCARBAZOLE-1-ALKANOIC ACIDS.
EP0307077A1 (en) * 1987-07-21 1989-03-15 Merck Frosst Canada Inc. Tetrahydrocarbazoles for the improvement of cyclosporin therapy
PT95692A (en) * 1989-10-27 1991-09-13 American Home Prod PROCESS FOR THE PREPARATION OF INDOLE-, INDENO-, PYRANOINDOLE- AND TETRA-HYDROCARBAZOLE-ALCANOIC ACID DERIVATIVES, OR WHICH ARE USEFUL AS PLA2 INHIBITORS AND LIPOXIGENASE
JP2004010601A (en) * 2002-06-11 2004-01-15 Nippon Steel Chem Co Ltd Method for producing indole derivative and intermediate useful for the same
CA2512704A1 (en) 2003-01-14 2004-08-05 Merck & Co., Inc. Geminally di-substituted nsaid derivatives as abeta 42 lowering agents
MXPA05011850A (en) * 2003-05-06 2006-05-25 Air Prod & Chem Hydrogen storage reversible hydrogenated of pi-conjugated substrates.
WO2005016882A1 (en) * 2003-08-15 2005-02-24 Universite Laval Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbazoles
CA2855759C (en) * 2011-11-15 2020-03-10 Yissum Research Development Company Of The Hebrew University Of Jerusam Ltd. Tricyclic compounds, compositions comprising them and uses thereof
JP5940036B2 (en) * 2013-10-08 2016-06-29 テックフィールズ バイオケム カンパニー リミテッド Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin permeability
WO2021193708A1 (en) * 2020-03-25 2021-09-30 Jnc株式会社 Compound, liquid crystal composition, and liquid crystal display element

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70880A (en) *
US3580926A (en) * 1969-11-10 1971-05-25 Parke Davis & Co Carbazole-4-alkanoic acids and tetrahydrocarbazole-4-alkanoic acids
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0060445A1 (en) * 1981-03-12 1982-09-22 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Process for the resolution of racemates and lactone esters used in said process
EP0239306A2 (en) 1986-03-27 1987-09-30 Merck Frosst Canada Inc. Tetrahydrocarbazole esters
EP0304156A1 (en) * 1987-07-21 1989-02-22 Merck Frosst Canada Inc. Cyclohept b indolealkanoic acids
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators

Also Published As

Publication number Publication date
DE2337340C2 (en) 1985-05-02
AT325607B (en) 1975-10-27
IE37942L (en) 1974-01-24
ZA734047B (en) 1974-03-27
AR205331A1 (en) 1976-04-30
NL7310275A (en) 1974-01-28
JPS4943973A (en) 1974-04-25
NL169877B (en) 1982-04-01
CH587819A5 (en) 1977-05-13
JPS5740144B2 (en) 1982-08-25
HU167611B (en) 1975-11-28
DK138537C (en) 1979-03-05
FR2193611A1 (en) 1974-02-22
AU475534B2 (en) 1976-08-26
AU5839073A (en) 1975-01-23
NO142865B (en) 1980-07-28
MY7800315A (en) 1978-12-31
LU68071A1 (en) 1975-04-11
SE402283B (en) 1978-06-26
CA1026348A (en) 1978-02-14
SU509220A3 (en) 1976-03-30
NL169877C (en) 1982-09-01
ATA649773A (en) 1975-01-15
IL42799A (en) 1977-03-31
KR780000289B1 (en) 1978-08-10
DK138537B (en) 1978-09-25
SE7605813L (en) 1976-05-21
FI59244B (en) 1981-03-31
FI59244C (en) 1981-07-10
BE802596A (en) 1974-01-21
DD107681A5 (en) 1974-08-12
IE37942B1 (en) 1977-11-23
NO142865C (en) 1980-11-05
DE2337340A1 (en) 1974-02-14
FR2193611B1 (en) 1976-05-14
HK49878A (en) 1978-09-08
IL42799A0 (en) 1973-10-25
KE2847A (en) 1978-06-30

Similar Documents

Publication Publication Date Title
GB1385620A (en) Carbazoles
ES2173279T3 (en) METHOD FOR MAKING (S) -3- (AMINOMETILO) -5-METILOHEXANOIC ACID.
ES442684A1 (en) Carbazoles
CO5720995A2 (en) NEW COMPOUND
GB1180873A (en) Amino-Esters of Substituted 4-Pentynoic-2-Acid, their Salification products and their method of manufacture
ES8106308A1 (en) Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation.
EA200500122A1 (en) NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHODS OF THEIR USE
GB1455049A (en) Process for the manufacture of 3- 3,4-dihydroxy-phenyl-serine
GB1467110A (en) 4-phenyl-5-oxo-heptenoic acids
ES528561A0 (en) A PROCEDURE FOR THE PREPARATION OF NITRO ALIPHATIC COMPOUNDS
GB1285400A (en) Esters of substituted anthranilic acid
ES8104245A1 (en) Benzimidazole derivatives, their use, and compositions containing these derivatives
KR830002708A (en) Preparation method of alpha-carbamoyl-pyrrolepropionitrile and alpha-carbamoyl-pyrrolepropionitrile-containing preparations and their therapeutic applications
PT83667B (en) PROCESS FOR THE PREPARATION OF ACIDS AND {{((3-PYRIDINYL) METHYLENE} AMINO} OXY} -ALCANOIC ACIDS AND ESTERS AND OF PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
GB1334693A (en) Acenaphthene derivatives
MY130320A (en) 1-bromoethyl ethyl carbonate and its use in the preparation of 1''- ethoxycarbonyloxyethyl esters of penicillins and novel intermediates, methods for its preparation and 1-bromoethylchloroformate and 1-bromoethylbromoformate obtained as intermediates
GB1174673A (en) Substituted Phenyl Acetamides, a Process for their Manufacture and Preparations Containing Them
IE34145B1 (en) A process for the manufacture of amino acids and derivatives thereof
KR880011096A (en) Optically active oxo-isoindolinyl derivatives
GB1441941A (en) Process for the preparation of 5-substituted resorcinols and related intermediates
YU47003B (en) PROCEDURE FOR OBTAINING QUINOLON CARBONIC ACID INTERMEDIARIES
GB1418784A (en) Phosphorus containing pyrimidine compounds and pesticidal compositions comprising them
GB1251142A (en)
GB1443647A (en) Imadazole derivatives and a process for the manufacture thereof
ES8706646A1 (en) Cyclopropane derivates.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 19930722